BIO vs OLN · rev $2.58B vs rev $6.54B
BIO (BIO) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
BIO currently screens at market cap $0. OLN currently screens at market cap $2.62B.
Not investment advice. Open the BIO and OLN stock pages for the full models.
Not investment advice.